The Dream OCT is a next-generation optical coherence tomography (OCT) system that combines speed, depth, and multimodal imaging to elevate diagnostic precision.
It’s ability to visualise the retina using multiple modalities offers a more complete view of disease, enhancing both diagnosis and management.
Suitable for a wider patient range, including up to -33D of accommodation, it delivers posterior imaging up to 12 mm and anterior segment depth of 16.2 mm. As the first OCT-angiography with ultra-widefield imaging over 200°, it enables confident detection of peripheral retinal lesions.
For patients with diabetes, its true angio algorithm provides accurate vascular detail, minimising false positives and negatives. With real-time scan speeds of up to 400,000 Hz, Dream OCT captures ultra-high-resolution images in just five seconds.
The Dream OCT was due to launch in Australia at ODMAFair25, subject to approval by the Australian Therapeutic Goods Administration.
Contact: Ophthalmopro (AUS) 1300 578 288
